Pneumococcal carriage in rural Gambia prior to the introduction of pneumococcal conjugate vaccine: a population-based survey

Tropical Medicine & International Health : TM & IH
Effua UsufChristian Bottomley

Abstract

To evaluate pneumococcal colonisation before and after the introduction of pneumococcal conjugate vaccine (PCV) in eastern Gambia. Population-based cross-sectional survey of pneumococcal carriage between May and August 2009 before the introduction of PCV into the Expanded Program on Immunization. Nasopharyngeal swabs were collected from all household members, but in selected households, only children aged 6-10 years were swabbed. This age group participated in an earlier trial of a nine-valent PCV between 2000 and 2004. The prevalence of nasopharyngeal pneumococcal carriage in 2933 individuals was 72.0% in underfives (N = 515), 41.6% in children aged 5-17 (N = 1508) and 13.0% in adults ≥18 (N = 910) years. The age-specific prevalence of serotypes included in PCV7, PCV10 and PCV13 was 24.7%, 26.6% and 46.8% among children <5 years of age; 8.5%, 9.2% and 17.7% among children 5-17 years; and 2.5%, 3.3% and 5.5% among adults ≥18 years. The most common serotypes were 6A (13.1%), 23F (7.6%), 3 (7.3%), 19F (7.1%) and 34 (4.6%). There was no difference in the overall carriage of pneumococci between vaccinated and unvaccinated children 8 years after the primary vaccination with three doses of PCV (48.3% vs. 41.1%). Before the introducti...Continue Reading

References

Apr 22, 1989·BMJ : British Medical Journal·K P O'NeillB M Greenwood
Jul 27, 1996·Lancet·S K ObaroB M Greenwood
May 1, 1996·The Pediatric Infectious Disease Journal·T J O'DempseyB Greenwood
Oct 1, 1996·The Pediatric Infectious Disease Journal·N Lloyd-EvansB M Greenwood
Sep 9, 1999·The Journal of Infectious Diseases·N MbelleK P Klugman
Feb 15, 2003·The Pediatric Infectious Disease Journal·Katherine L O'BrienUNKNOWN World Health Organization Pneumococcal Vaccine Trials Carraige Working Group
Feb 15, 2003·The Pediatric Infectious Disease Journal·Katherine L O'BrienUNKNOWN World Health Organization Pneumococcal Vaccine Trials Carriage Working Group
Feb 27, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gili Regev-YochayEthan Rubinstein
Mar 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David GreenbergRon Dagan
Aug 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Philip C HillRichard A Adegbola
Jul 9, 2009·JAMA : the Journal of the American Medical Association·Elske J M van GilsElisabeth A M Sanders
Apr 28, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Philip C HillRichard A Adegbola
Apr 16, 2011·Lancet·Daniel M WeinbergerMarc Lipsitch
Aug 24, 2012·Expert Review of Vaccines·Birgit SimellUNKNOWN Pneumococcal Carriage Group
Oct 18, 2013·Journal of the Royal Society, Interface·Christian BottomleyValerie Isham
Jan 28, 2014·PloS One·Effua UsufAndrew Hall

❮ Previous
Next ❯

Citations

Jan 16, 2021·Human Vaccines & Immunotherapeutics·Kubra AykacMehmet Ceyhan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.